Increased uric acid levels in drug-naïve subjects with bipolar disorder during a first manic episode

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 34, Issue 6, 2010, Pages 819-821

  Salvadore, Giacomo ^a   Viale, Carlos I ^b   Luckenbaugh, David A ^a   Zanatto, Vanessa C ^b   Portela, Luiz V ^b   Souza, Diogo O ^b   Zarate, Carlos A ^a   Machado Vieira, Rodrigo ^a,c  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Bipolar disorder; Depression; Gout; Mania; Purines; Uric acid

Indexed keywords

URIC ACID;

ADULT; AGE DISTRIBUTION; ARTICLE; BIPOLAR DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; FEMALE; HUMAN; MALE; MANIA; PATHOPHYSIOLOGY; SEX DIFFERENCE; URIC ACID BLOOD LEVEL; ANALYSIS OF VARIANCE; BLOOD; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; SEVERITY OF ILLNESS INDEX;

ANALYSIS OF VARIANCE; BIPOLAR DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; MALE; SEVERITY OF ILLNESS INDEX; URIC ACID;

EID: 77955054039     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2010.02.027     Document Type: Article

References (17)

1. Akhondzadeh S., Milajerdi M.R., et al. Allopurinol as an adjunct to lithium and haloperidol for treatment of patients with acute mania: a double-blind, randomized, placebo-controlled trial. Bipolar Disord 2006, 8. 485-9.
2. Anumonye A., Reading H.W., et al. Uric-acid metabolism in manic-depressive illness and during lithium therapy. Lancet 1968, 1(7555). 1290-3.
3. Bowman G.L., Shannon J., et al. Uric acid as a central nervous system antioxidant. J Alzheimers Dis 2010, Jan 7 [Electronic publication ahead of print].
4. Burnstock G. Purinergic signalling and disorders of the central nervous system. Nat Rev Drug Discov 2008, 7(7):575-590.
5. De Berardis D., Conti C.M., et al. Evaluation of plasma antioxidant levels during different phases of illness in adult patients with bipolar disorder. J Biol Regul Homeost Agents 2008, 22(3):195-200.
6. First M., Spitzer R.L., Gibbon M., Williams J.B.W. Structured clinical interview for the DSM-IV-TR Axis I disorders - patient edition 2002, Biometrics Research Department, New York State Psychiatric Institute, New York, NY.
7. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured clinical interview for DSM-IV-TR Axis I disorders, research version, non-patient edition 2002, Biometrics Research, New York State Psychiatric Institute, New York, SCID-I/NP, 11/2002 Revision.
8. Jinnah H.A. Lesch-Nyhan disease: from mechanism to model and back again. Dis Model Mech 2009, 2(3-4). 116-21.
9. Kraeplin E. Manic-depressive insanity and paranoia 1921, Edinburgh.
10. Lorenzi T.M., Borba D.L., et al. Association of serum uric acid levels with emotional and affective temperaments. J Affect Disord 2009, Jun 11.
11. Machado-Vieira R., Lara D.R., et al. Therapeutic efficacy of allopurinol in mania associated with hyperuricemia. J Clin Psychopharmacol 2001, 21(6). 621-2.
12. Machado-Vieira R., Lara D.R., et al. Purinergic dysfunction in mania: an integrative model. Med Hypotheses 2002, 58(4):297-304.
13. Machado-Vieira R., Soares J.C., et al. A double-blind, randomized, placebo-controlled 4-week study on the efficacy and safety of the purinergic agents allopurinol and dipyridamole adjunctive to lithium in acute bipolar mania. J Clin Psychiatry 2008, 69(8). 1237-45.
14. McQuillin A., Bass N.J., et al. Case-control studies show that a non-conservative amino-acid change from a glutamine to arginine in the P2RX7 purinergic receptor protein is associated with both bipolar- and unipolar-affective disorders. Mol Psychiatry 2009, 14(6):614-620.
15. Ring H.A., Heller A.J., et al. Plasma uric acid levels in patients receiving anticonvulsant monotherapy. Epilepsy Res 1991, 8(3):241-244.
16. Young R.C., Biggs J.T., et al. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978, 133:429-435.
17. Zarate C.A., Manji H.K. Bipolar disorder: candidate drug targets. Mt Sinai J Med 2008, 75(3):226-247.